title: Improvement of heart-, lung-, and liver-performance during mechanical circulatory support by the Novacor-system.
abstract: OBJECTIVE
  Since its clinical introduction, the Novacor left ventricular assist system (LVAS) has proved to be a reliable and safe method for bridging to cardiac transplantation. To find out whether univentricular assistance is sufficient in patients with severe global heart failure, multi organ monitoring using the COLD system was performed.
  
  
  METHODS
  In seven patients (mean age 38.8 years), the wearable Novacor system N100 was implanted. Preoperatively, during the first 72 h thereafter and before heart transplantation right and left ventricular cardiac output, right ventricular ejection fraction, pulmonary-, intrathoracic-and total blood volume, extravascular lung water and excretory liver function were monitored by means of double indicator dilution technique with the COLD system. Conventional hemodynamic parameters have also been documented.
  
  
  RESULTS
  During left ventricular assistance, both pulmonary and systemic arterial cardiac outputs increased significantly (Student's t-test, P < 0.05). Right ventricular ejection fraction rose from 17 to 26%, preoperatively elevated pulmonary and intrathoracic blood volumes and extravascular lung water fell significantly to normal ranges. Total blood volume remained constant, excretory liver function improved markedly.
  
  
  CONCLUSIONS
  Pulmonary cardiac output improves due to the reduced right ventricular afterload by unloading the impaired left ventricle with the Novacor pump. The drop in pulmonary blood volume, intrathoracic blood volume and extravascular lung water also indicates a decrease of pulmonary congestion. Since total blood volume remains unchanged, a volume shift to the systemic circulation is suggested, resulting in an improved splanchnic perfusion as demonstrated by a better excretory liver function. In the absence of primary pulmonary hypertension, treatment of global heart failure with a left ventricular assist device is possible. The COLD system is a useful tool for managing this patient group during the postoperative period.
authors.affiliation: Department of Cardiac Surgery, Ludwig-Maximilians-University, Grosshadern Medical Center, Munich, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Roell
authors.forename: O
authors.initials: O
authors.lastname: Goedje
authors.forename: H O
authors.initials: HO
authors.lastname: Vetter
authors.forename: C
authors.initials: C
authors.lastname: Schmitz
authors.forename: O
authors.initials: O
authors.lastname: Dewald
authors.forename: B
authors.initials: B
authors.lastname: Reichart
mesh_terms: D000328:Adult; D001810:Blood Volume; D004395:Dye Dilution Technique; D006321:Heart / Q000503:physiopathology*; D006353:Heart-Assist Devices; D006439:Hemodynamics; D006801:Humans; D008099:Liver / Q000503:physiopathology*; D008168:Lung / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods; D011184:Postoperative Period; D013152:Splanchnic Circulation; D016278:Ventricular Function, Right